NAMPT could become a predictive marker of anti-PD-L1 therapy, and this would be an important finding if confirmed also in melanoma, thinking to combination therapy with NAMPT inhibitor and/or blocking antibody [175,196,197] with targeted and immunotherapy. The gene discussed is NAMPT; the disease is melanoma.